Search Within

Maura N Dickler

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (31)
Groups
  1. Biostatistics Service (66)
  2. Epidemiology and Biostatistics (66)
  3. Survivorship Research (62)
  4. Department of Medicine (58)
  5. Solid Tumor Oncology Division (58)
  6. Breast Medicine Service (57)

More Groups

People
  1. Clifford Hudis (52)
  2. Sujata Patil (35)
  3. Larry Norton (33)
  4. Chau Dang (22)
  5. Gabriella D'Andrea-Carlino (21)
  6. Shari Goldfarb (19)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (3)
  4. 2017 (5)
  5. 2016 (2)
  6. 2015 (9)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Cancer Research (12)
  3. Clinical Cancer Research (7)
  4. Breast Cancer Research and Treatment (6)
  5. Cancer (2)
  6. Clinical Breast Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (20)
  3. Springer (8)
  4. Elsevier Inc. (3)
  5. Elsevier Ireland Ltd. (2)
  6. Oxford University Press (2)

More Publishers

Results (66)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A feasibility study of bevacizumab plus dose-dense doxorubicin- cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer
    Journal Article

    Mcarthur, H. L.; Rugo, H.; Nulsen, B.; Hawks, L.; Grothusen, J.; Melisko, M.; Moasser, M.; Paulson, M.; Traina, T.; Patil, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Rugo, H. S.; Caravelli, J. F.; Patil, S.; Yeh, B.; Melisko, M. E.; Park, J. W.; Geneus, S.; Paulson, M.; Grothusen, J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer
    Journal Article

    Morris, P. G.; Lynch, C.; Feeney, J. N.; Patil, S.; Howard, J.; Larson, S. M.; Dickler, M.; Hudis, C. A.; Jochelson, M.; Mcarthur, H. L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    Journal Article

    Traina, T. A.; Poggesi, I.; Robson, M.; Asnis, A.; Duncan, B. A.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Panageas, K.; more...
    Breast Cancer Research and Treatment (2008)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save